Stocks
Arena Pharmaceuticals (ARNA) R&D/CAPEX US GAAP (year values) |
|||||||||
| 2017 | 2018 | 2019 | 2020 | 2021 | LTM ? | CAGR 5 years ? | |||
| R&D/CAPEX, % | 62 821% | 16 623% | 4 804% | 39 480% | 591.0% | 591.0% | |||
| Changes by years, y/y, % | +55 829pp | -46 199pp | -11 819pp | +34 677pp | -38 890pp | -39.0% | |||
Arena Pharmaceuticals. R&D/CAPEX, %
Arena Pharmaceuticals. R&D/CAPEX, changes, pp
Arena Pharmaceuticals (ARNA) R&D/CAPEX US GAAP (quarter values) |
||||||||
| 2020Q4 | 2021Q1 | 2021Q2 | 2021Q3 | 2021Q4 | LTM ? | |||
| R&D/CAPEX, % | 73 854% | 105 706% | 54 855% | 134.2% | 20 702% | 591.0% | ||
| Changes by years, y/y, % | +69 897pp | +90 944pp | -161 632pp | -65 292pp | -53 152pp | |||
| Changes by quarters, q/q, % | +8 427pp | +31 853pp | -50 851pp | -54 721pp | +20 568pp | |||
